Cargando…
ITGA2 as a potential nanotherapeutic target for glioblastoma
High grade gliomas, including glioblastoma (GBM), are the most common and deadly brain cancers in adults. Here, we performed a quantitative and unbiased screening of 70 cancer-related antigens using comparative flow cytometry and, for the first time, identified integrin alpha-2 (ITGA2) as a novel mo...
Autores principales: | Guo, Peng, Moses-Gardner, Alexander, Huang, Jing, Smith, Edward R., Moses, Marsha A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470144/ https://www.ncbi.nlm.nih.gov/pubmed/30996239 http://dx.doi.org/10.1038/s41598-019-42643-7 |
Ejemplares similares
-
Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme
por: Lim, Xin Yuan, et al.
Publicado: (2023) -
Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014) -
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021) -
Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma
por: Feng, Chen, et al.
Publicado: (2020) -
Nanotherapeutic Modulation of Human Neural Cells and Glioblastoma in Organoids and Monocultures
por: Zhang, Issan, et al.
Publicado: (2020)